Skip to main content
SpringerLink
Log in

Drug-induced sexual dysfunction

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Drug-induced sexual dysfunction is a relatively common yet poorly understood clinical problem. The mechanisms whereby various drug classes alter sexual function remain poorly documented. An attempt has been made, based on recent advances in sexual physiology, to clarify drug-induced sexual dysfunction on the basis of possible or probable mechanisms of action. It is hoped that this approach may ultimately allow the physician to rationally select pharmacologic agents which minimize deleterious effects on libido, erection, ejaculation and orgasm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmad S (1980) Hydralazine and male impotence (letter). Chest 78:358

    Google Scholar 

  2. Beitins IZ, Bayard F, Kowarski A, Migeon CJ (1973) The effect of ACTH administration on plasma testosterone, dihydrotestosterone and serum LH concentrations in normal men. Steroids 21:553

    Google Scholar 

  3. Bennett D (1961) Treatment of ejaculation praceox with monoamine — oxidase inhibitors (letter). Lancet II: 1309

    Google Scholar 

  4. Biron P (1979) Diminished libido with cimetidine therapy. Can Med Assoc J 121:404

    Google Scholar 

  5. Brindley G (1983) Phyiology of penile erection. Present at Annual Meeting of the American Urological Association, Las Vegas, Nevada

  6. Bulpitt CJ, Dollery CT (1973) Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J 3:485

    Google Scholar 

  7. del Pozo E, Brownwell J (1979) Prolactin I. Mechanisms of control, peripheral actions and modification by drugs. Horm Res 10:143

    Google Scholar 

  8. Drugs that cause sexual dysfunction. Med Lett Drugs Therapeutics 22:108

  9. Franks S, Jacobs HS, Nabarro JDN (1978) Hyperprolactinaemia and impotence. Clin Endocrinol 8:277

    Google Scholar 

  10. Goldstein I, Krane RJ (1983) Effects of hypotension on the hemodynamic of penile erections. Surg Forum (in press)

  11. Goldstein I, Krane RJ, Ottesen B, Fahrenkrug J, Wagner G (1983) Vasoactive intestinal polypeptide release during pelvic nerve stimulation penile erections. Invest Urol (in press)

  12. Green M, Berman S (1954) Failure of ejaculation produced by dibenzyline: preliminary report. Conn Med 18:30

    Google Scholar 

  13. Greenberg HR (1965) Erectile impotence during the course of tofranil therapy. Am J Psychiatry 121:1021

    Google Scholar 

  14. Gorski RA (1974) Barbiturates and sexual differentiation of the brain. In: Simmerman E, George R (eds) Narcotics and the hypothalamus. Raven Press, New York, p 197

    Google Scholar 

  15. Hyppa MT, Flack SC, Rinne OK (1975) Is l-dopa an aphrodisiac in patients with Parkinson's disease? In: Sandler M, Gessa GL (eds) Sexual behavior, pharmacology and biochemistry. Raven Press, New York, p 315

    Google Scholar 

  16. Jenkins RB, Groh RH (1970) Mental symptoms in Parkinson patients treated with l-dopa. Lancet II:177

    Google Scholar 

  17. Kedia KR, Markland C, Froley EE (1975) Sexual function following high retroperitoneal lymphadenectomy. J Urol 114:237

    Google Scholar 

  18. Kent JR, Biscohoff AJ, Arduno LJ, Mellinger GT, Byar DP, Hill M, Kozbur X (1973) Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma. J Urol 109:858

    Google Scholar 

  19. Khan A, Camel G, Perry HM Jr (1970) Clonidine (Catapres): a new antihypertensive agent. Curr Ther Res 12:10

    Google Scholar 

  20. Klinge E, Sjastrand ND (1977) Comparative study of some isolated mammalian smooth effectors of penile erection. Acta Physiol Scand 100:354

    Google Scholar 

  21. Kolodny RC, Masters, WH, Kolodner RM, Toro G (1974) Depression of plasma testosterone levels after chronic intensive marijuana use. N Engl J Med 290:872

    Google Scholar 

  22. Kolodny RC (1978) Effects of alpha-methyldopa on male sexual function. Sex Disab 1:223

    Google Scholar 

  23. Kotin J, Wilbert DE, Verburg D, Soldinger SM (1976) Thioridazine and sexual dysfunction. Am J Psychiatry 133:82

    Google Scholar 

  24. Knarr JW (1976) Impotence from propranolol? (letter). Ann Intern Med 86:259

    Google Scholar 

  25. Langley JN, Anderson HK (1895) The innervation of the pelvic and adjoining viscera. III. The external generative organs. J Physiol 19:85

    Google Scholar 

  26. Laschet V, Laschet L (1977) Antiandrogens in the treatment of sexual deviations of men. J Steroid Biochem 6:821

    Google Scholar 

  27. Melman A, Libin M, Tendler C (1983) Effect of chronic alphamethyldopa upon sexual function in adult male rat. J Urol 129:643

    Google Scholar 

  28. Metoprolol (1978) Med Lett Drugs Ther 20:97

    Google Scholar 

  29. Metz P, Wagner G (1981) Penile circumference and erection. Urology 18:268

    Google Scholar 

  30. Miller RA (1976) Propranolol and impotence (letter). Ann Intern Med 85:682

    Google Scholar 

  31. Money J, Yankowitz R (1967) The sympathetic-inhibiting effects of the drug insmelin on human male eroticism, with a note on mellaril. J Sex Res 3:69

    Google Scholar 

  32. Newman RJ, Salerno HR (1974) Sexual dysfunction due to methyldopa (letter). Br Med J 4:106

    Google Scholar 

  33. Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P (1971) Clonidine: a new antihypertensive agent. Am J Cardiogr 28:74

    Google Scholar 

  34. Page LB, Sidd JJ (1972) Medical management of primary hypertension. Part II. N Engl J Med 286:1018

    Google Scholar 

  35. Papadopoulos C (1980) Cardiovascular drugs and sexuality. Arch Intern Med 140:1341

    Google Scholar 

  36. Petri WM (1980) Sexual effects of antidepressants and psychomotor stimulant drugs. Mod Probl Pharmacopsychiatry 15:77.

    Google Scholar 

  37. Pinta ER (1978) Treatment of obsessive homosexual pedophilic fantasies with medroxyprogesterone acetate. Biol Psychiatry 13:369

    Google Scholar 

  38. Rapp MS (1979) Two cases of ejaculatory impairment realted to phenelzine. Am J Psychiatry 136:1200

    Google Scholar 

  39. Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH (1977) Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med 87:398

    Google Scholar 

  40. Sanchez RS, Murthy GG, Mehta J, Shreeve WW, Singh FR (1976) Pituitary-testicular axis in patients on lithium therapy. Fertil Steril 27:667

    Google Scholar 

  41. Shader RI (1964) Sexual dysfunction associated with thioridazine hydrochloride. JAMA 188:1007

    Google Scholar 

  42. Shader RI, Elkin R (1980) The effects of antianxiety and anti-psychotic drugs on sexual behavior. Mod Probl Pharmacopsychiatry 15:19

    Google Scholar 

  43. Sicuteri F (1974) Serotonin and sex in man. Pharmacol Res Commun 6:403

    Google Scholar 

  44. Sicuteri F, Delbene R, Anselmi B (1975) Aphrodisiac effect of testosterone in parachlorophenylalanine treated sexually deficient men. In: Sandler M, Gessa GL (eds) Sexual behavior pharmacology and biochemistry. Raven Press, New York, p 335

    Google Scholar 

  45. Siroky MB, Krane RJ (1979) Physiology of male sexual function. In: Krane RJ, Siroky MB (eds) Clinical neuro-urology, Little, Brown & Co, Boston, p 45

    Google Scholar 

  46. Sjostrand NO, Klinge E (1979) Principal mechanisms controlling penile retraction and protrusion in rabbits. Acta Physiol Scand 106:199

    Google Scholar 

  47. Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, et al (1983) Impotence in medical clinic outpatients. JAMA 249:1736

    Google Scholar 

  48. Stessman J, Ben-Ishay D (1980) Chlorthalidone-induced impotence. Br Med J 281:714

    Google Scholar 

  49. Stoffer SS, Hynes KM, Jiang N, Ryan RJ (1973) Digoxin and abnormal serum hormone levels. JAMA 225:1643

    Google Scholar 

  50. Tamagna EI, Lane W, Hershman JM, Carlson HE, Sturdevant RAL, Poland RE, Rubin RT (1979) Effect of chronic metoclopramide therapy on serum pituitary hormone concentrations. Horm Res 11:161

    Google Scholar 

  51. Urry RL, Dougherty KA, Lockett ATK (1976) Age-related changes in male rat reproductive organ weights and plasma testosterone concentrations after administration of a monoamine oxidase inhibitor. Fertil Steril 27:1326

    Google Scholar 

  52. Van Thiel DH, Gavaler JS, Eagon PK, Chiao YB, Cobb CF, Lester R (1980) Alcohol and sexual function. Pharmacol Biochem Behav 13:125

    Google Scholar 

  53. Willis E, Ottesen B, Wagner G, Sundler F, Fahrenkrug J (1981) Vasoactive intestinal polypeptide release during pelvic nerve stimulation penile erection. Acta Physiol Scand 13:545

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Boston University School of Medicine, 02118, Boston, Massachusetts, USA

    Irwin Goldstein & Robert J. Krane

Authors
  1. Irwin Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Krane
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldstein, I., Krane, R.J. Drug-induced sexual dysfunction. World J Urol 1, 239–243 (1983). https://doi.org/10.1007/BF00326809

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00326809

Keywords

Search

Navigation